Emmanuel Messas

Inserm

Papers

1

Total Citations

25

H-Index

1

About

Emmanuel Messas is a leading figure in vascular medicine and interventional cardiology, whose research focuses on the non-invasive treatment of venous thromboembolism and the pathophysiology of arterial stiffness. His major contribution lies in pioneering high-frequency ultrasound as a tool for the non-invasive recanalization of deep venous thrombosis (DVT), a breakthrough that could transform the standard of care for this common and dangerous condition. In a landmark study published in 2020, Messas demonstrated the feasibility of this technique in a swine model, achieving successful clot dissolution with minimal trauma and enabling long-term follow-up (25 citations). This work, while still early-stage, has already garnered attention for its potential to replace invasive catheter-directed thrombolysis or surgery, offering a safer, office-based alternative for DVT patients. Beyond this, Messas has made significant contributions to understanding the role of arterial stiffness in cardiovascular risk, particularly in hypertension and aging. His research is characterized by a translational approach, bridging bench-to-bedside innovations with rigorous clinical validation. With a citation impact that continues to grow, Emmanuel Messas is a visionary whose work promises to reshape the management of vascular disease, making him a key figure for students and researchers interested in the future of non-invasive vascular interventions.

Research Focus

Key Achievements

1
H-Index
1
Papers
25
Total Citations
25
Avg Citations/Paper
🏆 Most Cited Paper
Non‐invasive recanalization of deep venous thrombosis by high frequency ultrasound in a swine model with follow‐up
25 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Inserm

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago